Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
PLoS One ; 19(5): e0303557, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38771840

RESUMO

BACKGROUND: Urinary tract infections (UTI) is a prevalent condition in those with diabetes, and in severe cases, it may escalate to sepsis. Therefore, it is important to analyze the risk variables associated with sepsis in diabetes individuals with UTI. METHODS: This research was a retrospective cross-sectional analysis. From January 2011 to June 2022, a group of individuals with diabetes were identified as having UTI at a tertiary hospital situated in Southeastern China. Patient data, including information on urine culture, was collected retrospectively from a clinical record database. The participants were categorized into the sepsis and non-sepsis groups. The risk variables were derived using both uni-and multiple- variable regression analysis. RESULTS: The research included 1919 patients, of whom 1106 cases (57.63%) had positive urine cultures. In total, 445 blood culture samples were tested, identifying 186 positive cases (41.80%). The prevalence of bacteria in urine and blood samples was highest for Escherichia coli and Klebsiella pneumoniae, respectively. Moreover, 268 individuals (13.97%) exhibited sepsis. The regression analysis indicated a positive correlation between sepsis and albumin (ALB)<34.35 g/L, C-reactive protein (CRP)>55.84 mg/L and white blood cell count (WBC) >8.485 X 109/L in diabetic cases with UTIs. By integrating the three aforementioned parameters, the area under the receiver operating characteristic curve was 0.809. CONCLUSIONS: The early detection of sepsis in diabetic individuals with UTI may be achieved using a comprehensive analysis of CRP, WBC, and ALB test findings.


Assuntos
Sepse , Infecções Urinárias , Humanos , Infecções Urinárias/complicações , Infecções Urinárias/microbiologia , Infecções Urinárias/epidemiologia , Masculino , Feminino , Sepse/complicações , Sepse/epidemiologia , Pessoa de Meia-Idade , Estudos Retrospectivos , Idoso , Estudos Transversais , Fatores de Risco , China/epidemiologia , Proteína C-Reativa/análise , Proteína C-Reativa/metabolismo , Diabetes Mellitus/epidemiologia , Adulto , Klebsiella pneumoniae/isolamento & purificação , Contagem de Leucócitos , Complicações do Diabetes/microbiologia , Complicações do Diabetes/epidemiologia
2.
Zhejiang Da Xue Xue Bao Yi Xue Ban ; 53(1): 126-130, 2023 Dec 12.
Artigo em Inglês, Chinês | MEDLINE | ID: mdl-38105675

RESUMO

A 82-year-old man was admitted to hospital with fever, unresponsiveness, elevated hypersensitive C-reactive protein and neutrophile granulocyte. Ceftriaxone was administrated by intravenous dripping in the emergency room, but the effect was not satisfactory. Following his admission to the ward, cefoperazone sulbactam were given. Elizabethkingia meningoseptica was identified by blood culture and further confirmed by 16S rRNA sequencing. The lumbar puncture showed that cerebrospinal fluid pressure was 80 mmH2O (1 mmH2O=0.0098 kPa) and biochemical results were normal. After 11 days of cefoperazone sulbactam treatment, the patient was discharged with negative blood culture. The hypersensitive C-reactive protein and neutrophile granulocyte had also declined. The patient received levofloxacin tablets for anti-infection treatment for 14 d after discharge. No signs of infection were observed in three months' following up.


Assuntos
Infecções por Flavobacteriaceae , Sepse , Masculino , Humanos , Idoso de 80 Anos ou mais , Proteína C-Reativa , Cefoperazona/uso terapêutico , Infecções por Flavobacteriaceae/diagnóstico , Infecções por Flavobacteriaceae/tratamento farmacológico , RNA Ribossômico 16S , Sulbactam/uso terapêutico
3.
Front Cell Infect Microbiol ; 13: 1267941, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37822356

RESUMO

Pasteurella multocida is an opportunistic pathogen. Previously reported infections associated with P. multocida have often been linked to contact with cats, dogs, and other animals. Cases of systemic multiple-site infections following P. multocida infection are rare. This case study presents a 49-year-old middle-aged man with post-hepatitis B cirrhosis and no history of animal contact. The patient was admitted with symptoms of fever accompanied by diarrhea, abdominal distension, and cough. Blood tests showed elevated levels of CRP, PCT, and IL-6, and blood culture revealed the growth of P. multocida. CT scans revealed a large amount of abdominal effusion, a small amount of pleural effusion, and pulmonary infection foci. The patient's condition improved after successive administration of ceftriaxone and levofloxacin to fight the infection, and abdominal puncture and drainage. Multiple-site infections caused by P. multocida are rarely encountered in patients with liver cirrhosis but without animal contact, which could be regarded as serious conditions warranting careful attention in terms of clinical diagnosis and treatment.


Assuntos
Doenças Transmissíveis , Infecções por Pasteurella , Pasteurella multocida , Peritonite , Pneumonia , Sepse , Masculino , Pessoa de Meia-Idade , Humanos , Animais , Gatos , Cães , Infecções por Pasteurella/complicações , Infecções por Pasteurella/diagnóstico , Infecções por Pasteurella/tratamento farmacológico , Cirrose Hepática/complicações , Sepse/complicações , Pneumonia/complicações
4.
BMJ Open ; 13(4): e067490, 2023 04 12.
Artigo em Inglês | MEDLINE | ID: mdl-37045577

RESUMO

OBJECTIVE: Escherichia coli (E. coli) is the most common opportunistic clinical micro-organism with high drug resistance. This study aimed to analyse the resistance pattern of E. coli according to patient age and clinical sample type. DESIGN AND SETTING: This retrospective observational study was conducted in a tertiary hospital in southeastern China. PARTICIPANTS: E. coli strains were isolated from blood, urine and sputum of infected inpatients. The patients were divided into four age groups: children (0-14 years old, including neonatal and non-neonatal groups), youths (15-40 years old), middle-aged (41-60 years old) and old (>60 years old). RESULTS: A total of 7165 E. coli strains were collected from all samples. Compared with urine and blood isolates, more sputum isolates were resistant against 12 tested antibiotics. Furthermore, urine isolates were more resistant to levofloxacin than sputum and blood isolates. Although the patients' age was not associated with resistance rates of E. coli strains isolated from blood, a larger proportion of urine-derived strains from youths were resistant to sulfamethoxazole-trimethoprim and piperacillin-tazobactam than those from old people. The sputum strains from the elderly were more resistant to most of the tested antibiotics compared with sputum strains isolated from children. CONCLUSIONS: The resistance profile of E. coli is different among age groups and specimen sources and should be considered during E. coli infection treatment.


Assuntos
Infecções por Escherichia coli , Escherichia coli , Criança , Idoso , Adolescente , Humanos , Pessoa de Meia-Idade , Recém-Nascido , Lactente , Pré-Escolar , Adulto Jovem , Adulto , Estudos Retrospectivos , Testes de Sensibilidade Microbiana , Antibacterianos/farmacologia , Antibacterianos/uso terapêutico , Infecções por Escherichia coli/tratamento farmacológico , Resistência Microbiana a Medicamentos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...